The Ultimate Solubility and Bioavailability Dream
• Well diversified IP from Unment medical need into supplements.
• Proven track record of benchmark, first in human, as well as projections into OTC and supplements.
• Manufacturing advantage of no more than 35% improvement in cost to scale up into large volume production.
• A healthy pipeline of products, diversified across therapeutic areas, expansion into repurposing of products into multiple life cycle indications.
• Increase the dose by 10- 30X, reduce the TEAEs by multiple folds in severity and frequency of the events. Give the products for a longer duration and expect many folds of efficacy over time.